People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aurion Biotech, Inc. | — | Biotechnology | Series C | $81.3M | $1.2B | 2022 |
JEANNETTE BANKES at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JEANNETTE BANKES on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew ElBardissi | 1 | 7 |
| David Rostov | 1 | 4 |
| Tom Frinzi | 1 | 3 |
| PATRICK LALLY | 1 | 1 |
| ARNAUD LACOSTE | 1 | 1 |
| CHRISTINE MCCAULEY | 1 | 1 |
| LINK WILLIAM | 1 | 1 |
| GREG KUNST | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.